GlassScriptPhysician profile
Jennifer Charity
NPI 1568439404
$1,445.86
in general payments reported to CMS, 2019-2025
17 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $76.86 · 2021: $217 · 2022: $182 · 2023: $267 · 2024: $259 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $753.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $442.51 | 2019-2025 | Vraylar |
| Silk Road Medical, INC. | $165.14 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Penumbra, INC. | $146.34 | 2022 | |
| Astellas Pharma US INC | $95.28 | 2025 | Veozah |
| Abbott Laboratories | $88.67 | 2021 | |
| Boston Scientific Corporation | $87.38 | 2021 | |
| Pfizer INC. | $70.91 | 2020-2024 | |
| Ibsa Pharma INC. | $64.59 | 2025 | Licart, Flector, Tirosint |
| Kowa Pharmaceuticals America, INC. | $58.82 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.05 | 2019-2020 | |
| Lilly USA, LLC | $38.98 | 2022-2024 | Mounjaro |
| Novo Nordisk INC | $35.07 | 2023-2025 | Wegovy |
| Otsuka America Pharmaceutical, INC. | $30.01 | 2022-2024 | Rexulti |
| Glaxosmithkline, LLC. | $24.84 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $22.89 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $20.36 | 2020 | |
| Lundbeck LLC | $14.02 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Charity listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.